Thursday, February 27, 2020
Financial News Conference Full Year 2019 Results
Location: Leverkusen, Baykomm (Bayer‘s Communication Center)
Bayer strategically and operationally successful
- Group sales advance by 3.5 percent (Fx & portfolio adj.) to 43.545 billion euros
- EBITDA before special items increases by 28.3 percent to 11.503 billion euros
- Core earnings per share up by 14.3 percent to 6.40 euros
- Net income rises 141.4 percent to 4.091 billion euros – gain of 1.637 billion euros on sale of Currenta stake
- Free cash flow of 4.214 billion euros above expectations
- Proposed dividend of 2.80 euros per share
- Crop Science shows solid performance in challenging environment, substantial increase in earnings due to acquired business
- Pharmaceuticals shows encouraging business development
- Sales growth at Consumer Health, earnings at prior-year level despite divestments
- Ongoing portfolio, structural and efficiency measures implemented successfully
- Glyphosate’s positive safety profile confirmed – appeal and mediation proceedings moving forward
- Outlook for 2020: increase in sales, earnings and free cash flow
- Ambitious sustainability targets set
Links
Recording of the Conference
Audio: MP3 for download (48.80 MB, 106:36 min.) (dubbed into English)
Speaker
Statement in written form and presentation slides
Recording (dubbed into English):
Video: Webcast of the speech with presentation slides (part 1)
Video: Webcast of the speech with presentation slides (part 2)
Audio: MP3 of the speech for download (part 1; MP3, 3.62 MB, 07:52 min.)
Audio: MP3 of the speech for download (part 2; MP3, 4.66 MB, 10:08 min.)
Recording (partly dubbed into English):
Video: Webcast of the discussion with presentation slides
Audio: MP3 of the discussion for download (MP3, 32.30 MB, 70:30 min.)